| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3476(05)82049-9 |
| P698 | PubMed publication ID | 1880650 |
| P50 | author | Helge Karch | Q1602385 |
| P2093 | author name string | Ludwig K | |
| Bitzan M | |||
| Heesemann J | |||
| Moebius E | |||
| Müller-Wiefel DE | |||
| P2860 | cites work | Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome | Q33371235 |
| Hemolytic-uremic syndrome in infants due to verotoxin-producing Escherichia coli | Q33396451 | ||
| Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome | Q33396788 | ||
| Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology | Q33397493 | ||
| Purification and characterization of a phage-encoded cytotoxin from an Escherichia coli O111 strain associated with hemolytic-uremic syndrome | Q33414067 | ||
| Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome | Q33426514 | ||
| Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases | Q33426826 | ||
| Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins | Q33428528 | ||
| Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome | Q33429198 | ||
| Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome | Q33442517 | ||
| The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. | Q33445781 | ||
| Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome | Q33445938 | ||
| Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes | Q33449435 | ||
| The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli | Q33457864 | ||
| Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools | Q33475757 | ||
| Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family | Q34050888 | ||
| Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype | Q34256166 | ||
| Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine | Q36215407 | ||
| Infection by verocytotoxin-producing Escherichia coli | Q36634680 | ||
| Alteration of the immunoglobulin G subclass responses in mice to lipopolysaccharide: effects of nonbacterial proteins and bacterial membrane phospholipids or outer membrane proteins of Proteus mirabilis | Q37110779 | ||
| Characterization of flagella purified from enterohemorrhagic, vero-cytotoxin-producing Escherichia coli serotype O157:H7. | Q37151695 | ||
| Detection and characterization of fecal verotoxin-producing Escherichia coli from healthy cattle | Q37185235 | ||
| Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli | Q40199619 | ||
| Yersinia enterocolitica serodiagnosis: a dual role of specific IgA. Evaluation of microagglutination and ELISA. | Q41518600 | ||
| Cloning and nucleotide sequence analysis of the genes determining verocytotoxin production in a porcine edema disease isolate of Escherichia coli | Q42653384 | ||
| A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of gram-negative bacteria | Q44839649 | ||
| Verotoxin receptor glycolipid in human renal tissue. | Q54736253 | ||
| False positive identifications of Escherichia coli O157 | Q69893419 | ||
| Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells | Q70240840 | ||
| Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli | Q71454940 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| antibody | Q79460 | ||
| hemolytic-uremic syndrome | Q162266 | ||
| lipopolysaccharide | Q421804 | ||
| P304 | page(s) | 380-385 | |
| P577 | publication date | 1991-09-01 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome | |
| P478 | volume | 119 |
| Q33494314 | A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators |
| Q42370652 | A recombinant O-polysaccharide-protein conjugate approach to develop highly specific monoclonal antibodies to Shiga toxin-producing Escherichia coli O157 and O145 serogroups |
| Q54625206 | An outbreak due to enterohaemorrhagic Escherichia coli O157:H7 in a children day care centre characterized by person-to-person transmission and environmental contamination. |
| Q33337454 | Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome |
| Q33395264 | Antibody response to Shiga toxins in Argentinean children with enteropathic hemolytic uremic syndrome at acute and long-term follow-up periods |
| Q33357487 | Characterization of the cytokine immune response in children who have experienced an episode of typical hemolytic-uremic syndrome |
| Q33991967 | Development of a blocking enzyme-linked immunosorbent assay for detection of serum antibodies to O157 antigen of Escherichia coli |
| Q28534818 | Dexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortex |
| Q33496709 | Diarrhea in young children associated with Escherichia coli non-O157 organisms that produce Shiga-like toxin |
| Q54658182 | Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls. |
| Q33359877 | Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children |
| Q33493394 | Epidemic Escherichia coli O157:H7 gastroenteritis and hemolytic-uremic syndrome in a Canadian inuit community: intestinal illness in family members as a risk factor |
| Q33329451 | Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. |
| Q33343335 | Escherichia coli 'O' group serological responses and clinical correlations in epidemic HUS patients |
| Q33330315 | Escherichia coli O157:H7 and O157:H(-) strains that do not produce Shiga toxin: phenotypic and genetic characterization of isolates associated with diarrhea and hemolytic-uremic syndrome. |
| Q35816742 | Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood |
| Q33394010 | Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease |
| Q33488736 | Escherichia coliO157:H7 and the Hemolytic–Uremic Syndrome |
| Q72797522 | Haemolytic anaemia in association with Escherichia coli O157 infection in two sisters |
| Q74183498 | Haemolytic uraemic syndrome |
| Q72674900 | Haemolytic-uraemic syndrome |
| Q33489318 | Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy. Italian HUS Study Group |
| Q33368494 | Hemolytic uremic syndrome due to Escherichia coli O157: H7 in a child with multiple infections |
| Q33598843 | Human response to Escherichia coli O157:H7 infection: antibodies to secreted virulence factors |
| Q35892930 | Immune response to verotoxin 1 and 2 in children with Escherichia coli O157:H7 hemorrhagic colitis and classic hemolytic uremic syndrome |
| Q33359241 | Impaired detection of faecal verocytotoxin in the presence of Clostridium difficile cytotoxin in patients with haemolytic uraemic syndrome |
| Q33365846 | Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome |
| Q54527541 | Introduction to the food safety concerns of verotoxin-producing Escherichia coli. |
| Q33497617 | Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture |
| Q33497678 | Lipopolysaccharide-specific antibodies in plasma and stools of children with Shigella-associated leukemoid reaction and hemolytic-uremic syndrome |
| Q55516340 | Modeling Hemolytic-Uremic Syndrome: In-Depth Characterization of Distinct Murine Models Reflecting Different Features of Human Disease. |
| Q33369263 | Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome |
| Q33499151 | Outbreak of Escherichia coli O157:H7 infection in a large family |
| Q24550740 | Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections |
| Q33338331 | Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. |
| Q34545082 | Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines |
| Q50138411 | Prevalence and clinical manifestations of Shiga toxin-producing Escherichia coli infections in Austrian children |
| Q33502574 | Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center |
| Q33361341 | Role of p38 MAP kinase pathway in a toxin-induced model of hemolytic uremic syndrome |
| Q34119320 | Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage. |
| Q64992859 | Roles of Shiga Toxins in Immunopathology. |
| Q33343456 | Saliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome |
| Q36526685 | Screening for Escherichia coli O157:H7--a nationwide survey of clinical laboratories. |
| Q33669516 | Sensitivities and specificities of premier E. coli O157 and premier EHEC enzyme immunoassays for diagnosis of infection with verotxin (Shiga-like toxin)-producing Escherichia coli. The SYNSORB Pk Study investigators |
| Q33412829 | Serodiagnosis using microagglutination assay during the food-poisoning outbreak in Japan caused by consumption of raw beef contaminated with enterohemorrhagic Escherichia coli O111 and O157 |
| Q33489309 | Serological detection of verocytotoxin-producingEscherichia coli in patients with haemolytic uraemic syndrome in Western Europe |
| Q24652310 | Shiga toxin 2 targets the murine renal collecting duct epithelium |
| Q33389321 | Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction |
| Q33342197 | Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome |
| Q34298167 | Shiga toxin-producing Escherichia coli: a single-center, 11-year pediatric experience. |
| Q33404640 | Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals |
| Q54539609 | Shiga-like toxin inhibition of FLICE-like inhibitory protein expression sensitizes endothelial cells to bacterial lipopolysaccharide-induced apoptosis. |
| Q33382082 | Sorbitol-fermenting enterohaemorrhagic Escherichia coli O157:H- causes another outbreak of haemolytic uraemic syndrome in children. |
| Q54663019 | The chemoluminescence response of human polymorphonuclear leukocytes to Escherichia coli O and K antigens |
| Q71041946 | The hemolytic uremic syndrome |
| Q43514801 | The multiplex-PCR-based detection and genotyping of diarrhoeagenic Escherichia coli in diarrhoeal stools |
| Q33494653 | The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study |
| Q33339090 | Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking |
| Q47998713 | Verotoxin-producing Escherichia coli in culled beef cows grazing rangeland forages |
| Q30441434 | p38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cells |
Search more.